Acceder

Publicaciones - Oftalmología Experimental

Cargando...
López-Hernández A.E., Miquel-López C., García-Medina J.J., García-Ayuso D. Impact of stimulant treatment on refractive errors and pupil diameter in attention deficit hyperactivity disorder. Acta Ophthalmologica. August 2024. 102:e842-e850. 10.1111/aos.16657
AÑO: 2024; IF: 2.8
Gramignoli R, Hofmann N, Agudo-Barriuso M, Antica M, Flores AI, Girandon L, Kerdjoudj H, Navakauskiene R, Schiavi J, Scholz H, Shablii V, Lafarge X, Nicolas FJ, Gindraux F. Expert Revision of Key Elements for Clinical-Grade Production and Qualification of Perinatal Derivatives. Stem Cells Transl Med. 2024 Jan 12;13(1):14-29. doi: 10.1093/stcltm/szad068. PubMed PMID: 38071447; PubMed Central PMCID: PMC10785218.
AÑO: 2024; IF: 4.9
Martinez-Vacas A, Di Pierdomenico J, Gomez-Ramirez AM, Vidal-Sanz M, Villegas-Perez MP, Garcia-Ayuso D. Dose-Related Side Effects of Intravitreal Injections of Humanized Anti-Vascular Endothelial Growth Factor in Rats: Glial Cell Reactivity and Retinal Ganglion Cell Loss. Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):10. doi: 10.1167/iovs.65.4.10. PubMed PMID: 38573620; PubMed Central PMCID: PMC10996988.
AÑO: 2024; IF: 4.7
Rodriguez-Ramirez KT, Norte-Munoz M, Lucas-Ruiz F, Gallego-Ortega A, Calzaferri F, Garcia-Bernal D, Martinez CM, Galindo-Romero C, de Los Rios C, Vidal-Sanz M, Agudo-Barriuso M. Retinal response to systemic inflammation differs between sexes and neurons. Front Immunol. 2024 Feb 7;15:1340013. doi: 10.3389/fimmu.2024.1340013. eCollection 2024. PubMed PMID: 38384465; PubMed Central PMCID: PMC10880026.
AÑO: 2024; IF: 5.9
Garcia-Ayuso D., Pierdomenico J.D., Martínez-Vacas A., Vidal-Sanz M., Picaud S., Villegas-Pérez M.P. Taurine: A promising nutraceutic in the prevention of retinal degeneration. Neural Regeneration Research. March 2024. 19:606-610. 10.4103/1673-5374.380820
AÑO: 2024; IF: 6.7
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII